JL14002

· Jecho Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JL14002, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD) [Phase 3]